Literature DB >> 7910542

The visualization of granulomatous disease with somatostatin receptor scintigraphy.

E Oztürk1, B Günalp, M Ozgüven, S Ozkan, T Sipit, Y Narin, H Bayhan.   

Abstract

In-111 labeled pentetreotide scintigraphy was applied to three patients with proven granulomatous disease (two with sarcoidosis, one with tuberculosis). All revealed accumulation of In-111 labeled pentetreotide in the granulomatous lesions, which was considered to be due to the presence of activated lymphocytes in these regions. This method may be of value in assessing the activity and extent of sarcoidosis and tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7910542

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  4 in total

Review 1.  Somatostatin receptor scintigraphy in thoracic diseases.

Authors:  P Ameri; F Gatto; M Arvigo; G Villa; E Resmini; F Minuto; G Murialdo; D Ferone
Journal:  J Endocrinol Invest       Date:  2007-11       Impact factor: 4.256

2.  Indium-111 octreotide scintigraphy in patients with bone tumours of the extremities.

Authors:  S Inanir; M Unlü; B Okudan; E Cila; S Atik
Journal:  Eur J Nucl Med       Date:  1996-08

3.  Somatostatin receptor imaging by SPECT and PET in patients with chronic inflammatory disorders: a systematic review.

Authors:  Luz Kelly Anzola; Andor W J M Glaudemans; Rudi A J O Dierckx; F Andres Martinez; Sergio Moreno; Alberto Signore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-28       Impact factor: 9.236

4.  Comparison of 68Ga-DOTANOC with 18F-FDG using PET/MRI imaging in patients with pulmonary tuberculosis.

Authors:  Claire M Naftalin; Francesca Leek; James T P D Hallinan; Lih Kin Khor; John J Totman; Jing Wang; Yee Tang Wang; Nicholas I Paton
Journal:  Sci Rep       Date:  2020-08-28       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.